Találatok a következőre: - Budapest

24.05.2016

Danish pharmaceutical company expands its capacity with a new laboratory in Kőbánya

The foundation stone of the new building of Xellia Pharmaceuticals has been placed at the Kőbánya-based premises of the Danish pharmaceutical company. The facility to be built in the framework of a development worth USD 10 million will contain advanced microbiological and chemical analytical laboratories and offices. The goal of the expansion is to ensure that a high-level product stability and pre-market testing can be carried out in the framework of centralised laboratory services.